ScholarWorks@SUNGKYUNKWAN UNIVERSITY

Journal for ImmunoTherapy of Cancer open-access icon

Journal Title

  • Journal for ImmunoTherapy of Cancer

ISSN

  • P 2051-1426 | 2051-1426

Publisher

  • BioMed Central
  • Springer Nature

Listed on(Coverage)

JCR2017-2019
SJR2014-2019
CiteScore2016-2019
SCIE2017-2021
SCOPUS2017-2020
MEDLINE2016-2021
DOAJ2017-2021
EMBASE2016-2020

OA Info.

OAopen-access icon

based on the information

  • 2017;2018;2019;2020;2021;
Keywordstumour immunology, cancer immunotherapy, immunotherapy biomarkers
Review ProcessBlind peer review
Journal info. pages
LicencesCC BY-NC, CC BY, CC BY-NC-ND
CopyrightsNo
DOAJ Coverage
  • Added on Date : 2013-09-23T15:36:59Z
Subject(s)Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • ENGLAND

Aime & Scopes

  • Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity. JITC publishes high quality original research articles, literature reviews, position papers and practice guidelines, and case reports; invited commentaries may also be commissioned by the journal. Together, these articles make JITC the leading forum for research in tumor immunology and cancer immunotherapy.

Homepage

Article List

1 - 20 out of 40 results.

SCIESCOPUS
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysisopen access

Jung, J.[Jung, J.]; Heo, Y.J.[Heo, Y.J.]; Park, S.[Park, S.]

ArticleIssue Date2023CitationJournal for immunotherapy of cancer, v.11, no.4PublisherNLM (Medline)
SCIESCOPUS
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatmentopen access

Kim, H.[Kim, H.]; Park, S.[Park, S.]; Han, K.-Y.[Han, K.-Y.]; Lee, N.[Lee, N.]; Kim, H.[Kim, H.]; Jung, H.A.[Jung, H.A.]; Sun, J.-M.[Sun, J.-M.]; Ahn, J.S.[Ahn, J.S.]; Ahn, M.-J.[Ahn, M.-J.]; Lee, S.-H.[Lee, S.-H.], et al.

ArticleIssue Date2023CitationJournal for ImmunoTherapy of Cancer, v.11, no.2PublisherBMJ Publishing Group
SCIESCOPUS
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironmentopen access

Park, M.[Park, M.]; Kuen, D.-S.[Kuen, D.-S.]; Park, J.[Park, J.]; Choi, M.[Choi, M.]; Kim, Y.[Kim, Y.]; Roh, E.C.[Roh, E.C.]; Choi, Y.J.[Choi, Y.J.]; Kim, Y.G.[Kim, Y.G.]; Chung, Y.[Chung, Y.]; Cho, S.Y.[Cho, S.Y.], et al.

ArticleIssue Date2023CitationJournal for ImmunoTherapy of Cancer, v.11, no.1PublisherBMJ Publishing Group
SCIESCOPUS
KEYNOTE-495/KEYIMPACT: UPDATED ANALYSIS OF A BIOMARKER-DIRECTED, RANDOMIZED, PHASE 2 TRIAL OF PEMBROLIZUMAB-BASED COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCERopen access

Herbst, R[Herbst, Roy]; Lam, WS[Lam, Wei-Sen]; Hellmann, M[Hellmann, Matthew]; Gubens, M[Gubens, Matthew]; Aggarwal, C[Aggarwal, Charu]; Tan, DSW[Tan, Daniel Shao Weng]; Felip, E[Felip, Enriqueta]; Chiu, J[Chiu, Joanne]; Lee, JS[Lee, Jong-Seok]; Yang, NCH[Yang, Names Chih-Hsin], et al.

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, pp.A666 - A666PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
A PHASE 1B/2 STUDY OF A NOVEL ANTI-CTLA-4 NEOBODYTM ADG116 MONOTHERAPY AND IN COMBINATION WITH TORIPALIMAB (TORI; ANTI-PD-1 ANTIBODY) IN PATIENTS WITH ADVANCED/METASTATIC SOLID TUMORSopen access

Park, J[Park, John]; Hsien, M[Hsien, Matthew]; Richardson, G[Richardson, Gary]; Tolcher, A[Tolcher, Anthony]; Chon, HJ[Chon, Hong Jae]; Shin, SJ[Shin, Sang Joon]; Lim, HY[Lim, Ho Yeong]; Hamid, A[Hamid, Anis]; Li, D[Li, Daneng]; Shi, K[Shi, Kristine], et al.

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, pp.A785 - A785PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
A PHASE 2 STUDY TO ASSESS THE SAFETY, EFFICACY OF FLX475 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC CANCERopen access

Rhee, P[Rhee, Paul]; Oh, DY[Oh, Do-Youn]; Ryu, MH[Ryu, Min Hee]; Hwang, JE[Hwang, Jun-Eul]; Cho, J[Cho, Jaeyong]; Zang, DY[Zang, Dae Young]; Oh, SC[Oh, Sang Cheul]; Lee, J[Lee, Jeeyun]; Lee, KW[Lee, Keun-Wook]; Rha, SY[Rha, Sun Young], et al.

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, pp.A689 - A689PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
IMMUNE CELL SUBTYPES ASSOCIATED WITH THE LEVEL OF TUMOR-INFILTRATING LYMPHOCYTES IN BREAST TUMOR MICROENVIRONMENTopen access

Cha, SM[Cha, Su Min]; Seo, JH[Seo, Jeong-Han]; Park, JW[Park, Jung-Wook]; Lee, HJ[Lee, Hee Jae]; Lee, HJ[Lee, Hee Jin]

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, pp.A1097 - A1097PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort studyopen access

Lee, JH[Lee, Ji Hyun]; Hyung, S[Hyung, Sujin]; Lee, J[Lee, Jeeyun]; Choi, SH[Choi, Sang-Hee]

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, no.8PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational studyopen access

Shui, IM[Shui, Irene M.]; Liu, XQ[Liu, Xiao Qiao]; Zhao, Q[Zhao, Qing]; Kim, ST[Kim, Seung Tae]; Sun, Y[Sun, Yuan]; Yearley, JH[Yearley, Jennifer H.]; Choudhury, T[Choudhury, Tasmiah]; Webber, AL[Webber, Andrea L.]; Krepler, C[Krepler, Clemens]; Cristescu, R[Cristescu, Razvan], et al.

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, no.7PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches

Won, JE[Won, Ji Eun]; Byeon, Y[Byeon, Youngseon]; Wi, TI[Wi, Tae In]; Lee, CM[Lee, Chan Mi]; Lee, JH[Lee, Ju Hyeong]; Kang, TH[Kang, Tae Heung]; Lee, JW[Lee, Jeong-Won]; Lee, Y[Lee, YoungJoo]; Park, YM[Park, Yeong-Min]; Han, HD[Han, Hee Dong]

ArticleIssue Date2022CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, no.2PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
PEGASUS HNSCC, A PLATFORM STUDY OF SAR444245 (THOR-707, A PEGYLATED RECOMBINANT NON-ALPHA IL-2) WITH ANTI-CANCER AGENTS IN PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA

Meng, RB[Meng, Robin]; Even, C[Even, Caroline]; Licitra, L[Licitra, Lisa]; Yen, CJ[Yen, Chia-Jui]; Ahn, MJ[Ahn, Myung Ju]; Abbadessa, G[Abbadessa, Giovanni]; Menas, FZ[Menas, Fatima-Zohra]; Zang, M[Zang, Miao]; Blumenschein, G[Blumenschein, George]

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A465 - A465PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
SPATIAL ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES CORRELATES WITH THE RESPONSE OF METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH VACTOSERTIB IN COMBINATION WITH PEMBROLIZUMAB

Kim, TW[Kim, Tae Won]; Lee, KW[Lee, Keun-Wook]; Ahn, JB[Ahn, Joong Bae]; Park, YS[Park, Young Suk]; Park, G[Park, Gahee]; Paeng, K[Paeng, Kyunghyun]; Ock, CY[Ock, Chan-Young]; Park, H[Park, Hyejoo]; Ryu, J[Ryu, Jiyeon]; Oh, B[Oh, Bitna], et al.

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A861 - A861PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
TUMOR MICROENVIRONMENT BASED ON PD-L1 AND CD8 T-CELL INFILTRATION CORRELATED WITH THE RESPONSE OF MSS MCRC PATIENTS TREATED VACTOSERTIB IN COMBINATION WITH PEMBROLIZUMAB

Kim, TW[Kim, Tae Won]; Lee, KW[Lee, Keun-Wook]; Ahn, JB[Ahn, Joong Bae]; Park, YS[Park, Young Suk]; Ock, CY[Ock, Chan-Young]; Park, H[Park, Hyejoo]; Ryu, J[Ryu, Jiyeon]; Oh, B[Oh, Bitna]; Kim, BK[Kim, Bo-Kyoung]; Hwang, S[Hwang, Sunjin], et al.

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A82 - A82PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
KEYNOTE-495/KEYIMPACT: INTERIM ANALYSIS OF A RANDOMIZED, BIOMARKER-DIRECTED, PHASE 2 TRIAL OF PEMBROLIZUMAB-BASED COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)

Gutierrez, M[Gutierrez, Martin]; Lam, WS[Lam, Wei-Sen]; Hellmann, M[Hellmann, Matthew]; Gubens, M[Gubens, Matthew]; Aggarwal, C[Aggarwal, Charu]; Tan, DSW[Tan, Daniel Shao Weng]; Felip, E[Felip, Enriqueta]; Chiu, JWY[Chiu, Joanne W. Y.]; Lee, JS[Lee, Jong-Seok]; Yang, JCH[Yang, James Chih-Hsin], et al.

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A485 - A485PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
TRIAL IN PROGRESS: A PHASE 2 STUDY TO ASSESS THE SAFETY, EFFICACY OF FLX475 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC CANCER

Oh, DY[Oh, Do-Youn]; Ryu, MH[Ryu, Min Hee]; Hwang, JE[Hwang, Jun-Eul]; Cho, J[Cho, Jaeyong]; Zang, DY[Zang, Dae Young]; Oh, SC[Oh, Sang Cheul]; Lee, J[Lee, Jeeyun]; Lee, KW[Lee, Keun-Wook]; Chung, HC[Chung, Hyun Cheol]; Shim, BY[Shim, Byoung Yong], et al.

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A440 - A440PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
EVORPACEPT (ALX148), A CD47 MYELOID CHECKPOINT INHIBITOR, IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) AND WITH GASTRIC/GASTROESOPHAGEAL CANCER (GC); ASPEN-01

Lee, KW[Lee, Keun-Wook]; Chung, H[Chung, Hyun]; Kim, TM[Kim, Tae Min]; Lakhani, N[Lakhani, Nehal]; Messersmith, W[Messersmith, Wells]; Santana-Davila, R[Santana-Davila, Rafael]; Kim, WS[Kim, Won Seog]; LoRusso, P[LoRusso, Patricia]; Bang, YJ[Bang, Yung-Jue]; Chow, L[Chow, Laura], et al.

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A530 - A530PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
EFFECTS OF PEMBROLIZUMAB ON THE TUMOR MICROENVIRONMENT (TME) AFTER ONE PRESURGERY TREATMENT CYCLE IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER (TNBC): PHASE 1B KEYNOTE-173 STUDY

Schmid, P[Schmid, Peter]; Park, YH[Park, Yeon Hee]; Munoz-Couselo, E[Munoz-Couselo, Eva]; Kim, SB[Kim, Sung-Bae]; Sohn, J[Sohn, Joohyuk]; Im, SA[Im, Seock-Ah]; Holgado, E[Holgado, Esther]; Foukakis, T[Foukakis, Theodoros]; Kummel, S[Kuemmel, Sherko]; Dent, R[Dent, Rebecca], et al.

ArticleIssue Date2021CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, pp.A364 - A364PublisherBMJ PUBLISHING GROUP
SCIESCOPUS
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric canceropen access

Zeng, D.[Zeng, D.]; Wu, J.[Wu, J.]; Luo, H.[Luo, H.]; Li, Y.[Li, Y.]; Xiao, J.[Xiao, J.]; Peng, J.[Peng, J.]; Ye, Z.[Ye, Z.]; Zhou, R.[Zhou, R.]; Yu, Y.[Yu, Y.]; Wang, G.[Wang, G.], et al.

ArticleIssue Date2021CitationJournal for ImmunoTherapy of Cancer, v.9, no.8PublisherBMJ Publishing Group
SCIESCOPUS
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer

Nam, G.-H.[Nam, G.-H.]; Kwon, M.[Kwon, M.]; Jung, H.[Jung, H.]; Ko, E.[Ko, E.]; Kim, S.A.[Kim, S.A.]; Choi, Y.[Choi, Y.]; Song, S.J.[Song, S.J.]; Kim, S.[Kim, S.]; Lee, Y.[Lee, Y.]; Kim, G.B.[Kim, G.B.], et al.

ArticleIssue Date2021CitationJournal for ImmunoTherapy of Cancer, v.9, no.7PublisherBMJ Publishing Group
SCIESCOPUS
PHASE 3 STUDY OF COMBINATION PEMBROLIZUMAB plus OLAPARIB THERAPY VERSUS ENZALUTAMIDE/ABIRATERONE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) AFTER PROGRESSION ON CHEMOTHERAPY (KEYLYNK-010)

Yu, E[Yu, Evan]; Park, SH[Park, Se Hoon]; Huang, YH[Huang, Yi-Hsiu]; Bennamoun, M[Bennamoun, Mostefa]; Xu, L[Xu, Lu]; Kim, J[Kim, Jeri]; Antonarakis, E[Antonarakis, Emmanuel]

ArticleIssue Date2020CitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.8, pp.A210 - A211PublisherBMJ PUBLISHING GROUP
1 2
STATISTICS
Total View :5,540,496
Today View :6,046

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어